mortality/aging
• 12- to 13-week old late generation (G4) mutants exhibit accelerated degeneration as indicated by hair graying, alopecia, kyphosis, reduced body size and weight, and fragility
|
neoplasm
• 98% of early generation mutants succumb to tumors with a median tumor-free latency of 38.6 weeks
• late generation mutants show a decrease in percent tumor death and an increase in tumor-free latency, from 98% to 43% and 38.6-65.3 weeks compared to early generation mutants
|
• 11% and 10% of early generation and late generation mutants, respectively, develop lymphomas
|
• 57% and 59% of early generation and late generation mutants, respectively, develop histocytic sarcomas
• 24% and 28% of early generation and late generation mutants, respectively, develop soft tissue sarcomas
|
cellular
• the anaphase bridge index (ABI) is increased to the same extent as in Terctm1Rdp homozygotes in late-generation (G4/G5) intestinal crypts indicating telomere dysfunction
|
|
• apoptotic depletion of germ cells in late generation mutants
|
• MEFs grown in culture show decreased growth rates after 10 population doublings with steady slow proliferation thereafter, indicating that telomere dysfunction suppresses the growth rate
• early generation (G0) astrocytes show continuous proliferation whereas the late generation (G4) astrocytes senesce after 2.5 population doublings, indicating that telomere dysfunction constrains the immortalization potential of astrocytes
|
reproductive system
|
• apoptotic depletion of germ cells in late generation mutants
|
|
• testicular atrophy and associated apoptotic depletion of germ cells in late generation mutants
|
growth/size/body
• late generation mutants have reduced body size and are fragile
|
• late generation mutants have reduced body weight
|
digestive/alimentary system
• the GI crypts of late generation mutants exhibit high levels of apoptosis
|
skeleton
endocrine/exocrine glands
|
• testicular atrophy and associated apoptotic depletion of germ cells in late generation mutants
|